---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-009317"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2022-05-11T23:59:59+00:00"
generated_at: "2026-06-25T21:12:48.405449+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teknova Q1 revenue $11.1M (+23% YoY); guides FY2022 revenue $45-48M

## Summary
- Q1 2022 revenue $11.1M up 23% YoY; Lab Essentials $6.98M, Clinical Solutions $3.81M, Sample Transport $6K.
- Net loss -$5.5M (-$0.20 diluted EPS) vs -$0.7M loss in Q1 2021; Adjusted EBITDA -$4.3M vs break-even.
- Cash position $76.5M; amended credit facility increased from $27M to $57M to fund growth.
- FY2022 revenue guidance of $45-48M (over 30% growth at midpoint); Lab Essentials ~25% growth, Clinical Solutions at least 60%.
- No material Sample Transport revenue expected in 2022; new manufacturing facility expected online by year end.

## SEC filing metadata
- accession: 0000950170-22-009317
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2022-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000095017022009317/0000950170-22-009317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000095017022009317/tkno-20220511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-009317
- JSON: https://secwatch.observer/filing/0000950170-22-009317.json
- Plain text: https://secwatch.observer/filing/0000950170-22-009317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.